• Having post TURBT, and considering alternate with cystoscopy to de-intensify surveillanc?
• Being followed up with no recurrence long term?

If yes, The AcornUI-MRD Test may be right for you.

AcornUI-MRD with a simple, objective urine test to detect recurrence of BC. AcornUI-MRD demonstrated high NPV, meaning that when receiving a negative result, may help you avoid unnecessary procedures and discomfort. AcornUI-MRD is a highly sensitive and specific test, which ensures more accurately assess the risk of recurrence or the presence of bladder cancer. AcornUI-MRD can be used in a surveillance regimen to increase confidence in detection of recurrence and/or to reduce amount of cystoscopies.

If you are concerned about the recurrence of bladder cancer, AcornUI-MRD can provide answers that will enable you and your doctor to make informed decisions about your care.

AcornUI-MRD offers a surveillance alternative that can alleviate the burden of cystoscopy for individuals being monitored for recurrent bladder cancer.

It is non-invasive, and easy-to-use. You do not need to visit the hospital. You only need to collect a urine sample at home and deliver it to us.

AcornUI-MRD provides a personalized risk score for you.

Results are usually written as "positive" or "negative".

• A positive result indicates a high risk of bladder cancer. It is recommended to follow your doctor's advice, consider results of other tests for a comprehensive evaluation, and schedule associated examinations if necessary.
• A negative result indicates a low risk of bladder cancer. It is advisable to consult with a clinical physician, maintain healthy lifestyle habits, and undergo regular physical examinations.